Dostarlimab and Cobolimab in Advanced Cervical Cancer

Conditions: Cervical Cancer; Advanced Cervical Carcinoma; Metastatic Cervical Cancer; Metastatic Cervical Carcinoma; Recurrent Cervical Carcinoma Interventions: Drug: Dostarlimab; Drug: Cobolimab Sponsors: Meghan Shea; GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials